carbonthatcarbonthat
← Every company

Supernus Pharmaceuticals Inc Insider Trading

Every director, officer and 10% holder of Supernus Pharmaceuticals Inc has to report each trade in its stock within two business days of making it. This is those filings.

SUPN on carbonthat →
Insiders filing
5
20 reported lines
Open-market buys
0
Open-market sales
0
Net
—
bought more

Purchases and sales

Open-market trades only — the lines where someone chose to buy or sell at the going price.

No open-market trades

Every line on file for this company is compensation rather than a decision. Show everything to see them.

Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.

More on SUPN

Company overviewEverything on SUPN in one place, with the price.SEC filingsWhat SUPN's 8-Ks say happened: results, departures, auditor changes.Executive payWhat SUPN awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in SUPN.Funds holding itWhich funds and ETFs hold SUPN, and how big a bet.LobbyingWhat SUPN spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on SUPN's account, and who they worked for.PatentsWhat SUPN is filing at the patent office.

Follow Supernus Pharmaceuticals Inc (SUPN) by email

New trades in Supernus Pharmaceuticals Inc (SUPN) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

PeopleCEOs, investors, public officials and market commentators.SEC FilingsAuditor changes, restatements, departures and results, from 8-Ks.Insider BuyingCluster buys, and chief executives buying their own stock.The InsidersOne page per filer: every company they file against.